Kura Oncology, Inc.KURANASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank86
3Y CAGR+69.7%
5Y CAGR+14.1%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+69.7%/yr
vs -30.3%/yr prior
5Y CAGR
+14.1%/yr
Recent acceleration
Acceleration
+100.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.12M-30.9%
2024$1.62M+4.5%
2023$1.55M+576.4%
2022$229000.00-44.7%
2021$414000.00-28.4%
2020$578000.00-0.3%
2019$580000.00-40.2%
2018$970000.00+9.2%
2017$888000.00+53.9%
2016$577000.00-